Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Trial Supply & Logistics Market by Services (Comparator Sourcing, Logistics & Distribution, Manufacturing), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, Therapeutic Area, End User - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering.
Expanding at a Remarkable CAGR, the Clinical Trial Supply & Logistics Market Forecasts a Significant Upsurge by 2030
The Clinical Trial Supply & Logistics Market is set to witness formidable growth, according to a newly compiled research publication. The market, highly responsive to the surging demand for comparator sourcing, logistics & distribution, and manufacturing services, is expected to advance at a Compound Annual Growth Rate (CAGR) of 7.74%, burgeoning from USD 24.33 billion in 2023 to an estimated USD 41.04 billion by 2030.
The research offers nuanced insights into the proliferating necessities of biologic drugs, medical devices, and small molecules across multifarious clinical trial phases. The meticulous attention given to therapeutic areas including oncology, CNS & mental disorders, among others, signifies how the market is evolving to accommodate diverse clinical needs.
Regional Spectrum of Clinical Trial Supply & Logistics Market
Emerging atop the Global Clinical Trial Supply & Logistics scene is the Americas, with North America, particularly the United States, being a hotbed for pharmaceutical R&D investment. Asia-Pacific regions are gaining momentum owing to thriving pharmaceutical landscapes, with countries like China and India demonstrating robust growth in clinical trial activities. Europe continues to be a vital player, bolstered by stringent regulations ensuring the quality of clinical trial supplies.
Targeted Evaluation through FPNV Positioning Matrix
The disclosure further includes a thorough assessment through the FPNV Positioning Matrix, categorizing vendors based on business strategy excellence and product satisfaction. Enhanced understanding of the vendor landscape facilitates informed decision-making for stakeholders and contributes to the strategic direction of the market.
Incorporating Market Share Analysis
Complementary to competitor analysis, the Market Share Analysis segment of the report offers a detailed scrutiny of vendors' impact on the market. It helps companies grasp the competitive distribution and guides them to refine their strategies for a tangible market presence.
Insightful Profiles of Key Companies
The research orbits around the market's major players, dissecting recent developments and offering a horizon of strategic endeavors in the sector. Company profiles in the research include top-tier entities that are steering the course of clinical trial supply and logistics globally.
Market Segmentation & Coverage
An exhaustive segmentation analysis is the cornerstone of the research, covering:
- Services: Comparator Sourcing, Logistics & Distribution, Cold Chain Distribution, Non-Cold Chain Distribution, Manufacturing, Packaging, Labeling, & Blinding, Storage & Retention
- Type: Biologic Drugs, Medical Devices, Small Molecules
- Phase: BA/ BE studies, Phase 1 through Phase 4
- Therapeutic Area: From Blood Disorders to Rare Diseases
- End User: CROs, Medical Devices Companies, Pharmaceutical & Biotechnology companies
- Region: Geographical analysis spanning the Americas, Asia-Pacific, Europe, Middle East & Africa
The report's findings spotlight strategic dynamics within the market and reveal critical trajectories for growth, shaping the future of the Clinical Trial Supply & Logistics landscape.
Dedicated to equipping stakeholders with an actionable roadmap, the report addresses sensitive questions related to market size and forecasts, product developments, technology trends, regulatory frameworks, competitive intelligence, market penetration, and diversification strategies. It's poised to be an invaluable resource for industry players worldwide.
With the market's acceleration influenced by increasing investment in healthcare infrastructure and a surge in global demand for advanced clinical trial services, the Clinical Trial Supply & Logistics domain stands on the precipice of a new era of growth and innovation.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 184 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $24.33 Billion |
| Forecasted Market Value (USD) by 2030 | $41.04 Billion |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Global |
Companies Mentioned
- Almac Group
- Ancillare, LP
- Beroe Holdings Inc.
- Biocair International Limited
- Catalent, Inc.
- Clinigen Group PLC
- COREX LOGISTICS LIMITED
- Deutsche Post AG
- Eurofins Scientific Group
- ICON PLC
- Inceptua S.A.
- Infosys Limited
- KLIFO A/S
- Liveo Research GmbH
- Lonza Group AG
- Marken Limited
- Myonex, Inc.
- N-SIDE SA
- Octalsoft
- Parexel International Corporation
- PCI Pharma Services
- PHOENIX Pharmahandel GmbH & Co KG
- Piramal Pharma Solutions
- SAP SE
- Signant Health
- SIRO Clinpharm Private Limited
- Thermo Fisher Scientific, Inc.
- Walden Group
For more information about this report visit https://www.researchandmarkets.com/r/l8pkom
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
